{
    "2021-09-26": [
        [
            {
                "time": "",
                "original_text": "医药生物行业：绿色制药 遇上“限电”-“限电”政策对API及CDMO公司影响点评",
                "features": {
                    "keywords": [
                        "绿色制药",
                        "限电",
                        "API",
                        "CDMO"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：海外新冠治疗药物有望Q4陆续获批 重点推荐相关CDMO标的",
                "features": {
                    "keywords": [
                        "新冠治疗药物",
                        "Q4获批",
                        "CDMO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "临床CRO行业深度报告：中国临床CRO好时代来了？",
                "features": {
                    "keywords": [
                        "临床CRO",
                        "中国",
                        "好时代"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业研究周报：从医疗服务价格调整看康复行业机会(第79篇)",
                "features": {
                    "keywords": [
                        "医疗服务",
                        "价格调整",
                        "康复行业"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物",
                        "康复"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：医保局回应种植牙问题 牙科集采会不会来？",
                "features": {
                    "keywords": [
                        "医保局",
                        "种植牙",
                        "牙科集采"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "牙科"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}